Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series

Domingo E., Camps C., Kaisaki PJ., Parsons MJ., Mouradov D., Pentony MM., Makino S., Palmieri M., Ward RL., Hawkins NJ., Gibbs P., Askautrud H., Oukrif D., Wang H., Wood J., Tomlinson E., Bark Y., Kaur K., Johnstone EC., Palles C., Church DN., Novelli M., Danielsen HE., Sherlock J., Kerr D., Kerr R., Sieber O., Taylor JC., Tomlinson I.

DOI

10.1016/s2468-1253(18)30117-1

Type

Journal article

Journal

The Lancet Gastroenterology & Hepatology

Publisher

Elsevier BV

Publication Date

09/2018

Volume

3

Pages

635 - 643

Permalink Original publication